VERVE THERAPEUTICS INC's ticker is VERV and the CUSIP is 92539P101. A total of 128 filers reported holding VERVE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.34 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $263,000 | -17.8% | 19,880 | +16.4% | 0.00% | – |
| Q2 2023 | $320,000 | +98.8% | 17,079 | +52.2% | 0.00% | – |
| Q1 2023 | $161,000 | -33.7% | 11,223 | -10.4% | 0.00% | – |
| Q4 2022 | $243,000 | -2.8% | 12,523 | +71.9% | 0.00% | – |
| Q3 2022 | $250,000 | +1370.6% | 7,286 | +544.2% | 0.00% | – |
| Q2 2022 | $17,000 | -70.7% | 1,131 | -56.0% | 0.00% | – |
| Q1 2022 | $58,000 | -77.7% | 2,571 | -63.4% | 0.00% | – |
| Q4 2021 | $260,000 | -37.5% | 7,026 | -20.7% | 0.00% | – |
| Q3 2021 | $416,000 | -2.8% | 8,860 | +24.8% | 0.00% | – |
| Q2 2021 | $428,000 | – | 7,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alphabet Inc. | 10,974,011 | $661,184,000 | 13.47% |
| Casdin Capital, LLC | 3,038,167 | $183,050,000 | 4.65% |
| Logos Global Management LP | 758,265 | $45,685,000 | 3.84% |
| Novo Holdings A/S | 793,265 | $47,794,000 | 2.12% |
| Redmile Group, LLC | 1,936,530 | $116,676,000 | 1.73% |
| Cormorant Asset Management, LP | 709,224 | $40,594,000 | 1.38% |
| Rock Springs Capital Management LP | 962,826 | $58,011,000 | 1.15% |
| Asymmetry Capital Management, L.P. | 24,790 | $1,494,000 | 1.03% |
| Darwin Global Management, Ltd. | 103,013 | $6,207,000 | 1.00% |
| RA Capital Management | 880,284 | $53,037,000 | 0.85% |